“It’s all in a decade’s work”: A Ten-Year Retrospective Report on the IMPT

image: floating cards with different years written on each card

Multipurpose prevention technologies (MPTs) are safe, effective, accessible, and acceptable tools for women that combine prevention of at least two sexual and reproductive health (SRH) risks, including HIV, other STIs, and unintended pregnancy. Despite important advances in the family planning, STI prevention, and HIV prevention fields, condoms were the only available method for comprehensive SRH protection at the founding of the MPT field in 2009, and remain a critical component of the method mix today. Taking a page from the family planning field, however, the MPT field was founded on the idea that a ‘suite’ of multipurpose prevention products would better meet a woman’s needs throughout her life course.

View the interactive report.

10 years ago, in 2009, the MPTs field was formalized alongside the launch of the Initiative for MPTs (IMPT)—a product neutral backbone organization established to facilitate action-oriented collaborations aimed at driving this new field forward. The IMPT is a project of PHI’s CAMI Health, an organization dedicated to improving the health of women and girls worldwide.

In this 10-year retrospective report, the IMPT highlights advances in the MPT field that have synergistically combined to bring MPTs continually closer to a reality that will improve the lives of women and girls worldwide. Explore the report.

Originally published by CAMI Health

Work With Us

You change the world. We do the rest. Explore fiscal sponsorship at PHI.

Bring Your Work to PHI

Support Us

Together, we can accelerate our response to public health’s most critical issues.


Find Employment

Begin your career at the Public Health Institute.

See Jobs

Emergency room nurse talks with patient


New Study: ED Buprenorphine Linked to Sustained Opioid Use Disorder Treatment

Patients who get their first dose of buprenorphine in the Emergency Department (ED) are more likely to remain engaged in opioid use disorder treatment 30 days post-discharge, finds a new study from PHI's CA Bridge—reinforcing EDs as critical access points to highly effective, life-saving medication for addiction treatment.

read the study

Continue to